Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-03T02:54:14.520Z Has data issue: false hasContentIssue false

The problem of nitrogen disposal in the obese

Published online by Cambridge University Press:  06 February 2012

Marià Alemany*
Affiliation:
Department of Nutrition and Food Science, Faculty of Biology, University of Barcelona, Barcelona, Spain CIBER Nutrition and Obesity, Institute of Health Carlos III, Barcelona, Spain
*
*Corresponding author: Professor Marià Alemany, fax +34 934037064, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Amino-N is preserved because of the scarcity and nutritional importance of protein. Excretion requires its conversion to ammonia, later incorporated into urea. Under conditions of excess dietary energy, the body cannot easily dispose of the excess amino-N against the evolutively adapted schemes that prevent its wastage; thus ammonia and glutamine formation (and urea excretion) are decreased. High lipid (and energy) availability limits the utilisation of glucose, and high glucose spares the production of ammonium from amino acids, limiting the synthesis of glutamine and its utilisation by the intestine and kidney. The amino acid composition of the diet affects the production of ammonium depending on its composition and the individual amino acid catabolic pathways. Surplus amino acids enhance protein synthesis and growth, and the synthesis of non-protein-N-containing compounds. But these outlets are not enough; consequently, less-conventional mechanisms are activated, such as increased synthesis of NO followed by higher nitrite (and nitrate) excretion and changes in the microbiota. There is also a significant production of N2 gas, through unknown mechanisms. Health consequences of amino-N surplus are difficult to fathom because of the sparse data available, but it can be speculated that the effects may be negative, largely because the fundamental N homeostasis is stretched out of normalcy, forcing the N removal through pathways unprepared for that task. The unreliable results of hyperproteic diets, and part of the dysregulation found in the metabolic syndrome may be an unwanted consequence of this N disposal conflict.

Type
Review Article
Copyright
Copyright © The Author 2012

Introduction

When compared with the metabolism of carbohydrates and lipids, amino acid metabolism in man has been only sparsely studied in relation to overall energy metabolism. The roles of protein in starvation(Reference Felig, Owen and Wahren1, Reference Goodman, Belur and Lowell2) and malnutrition(Reference Smith, Pozefsky and Chhetri3, Reference Frenk4), however, have received more attention; however, in any case, our actual knowledge of N metabolism in man is far more limited than the detailed information available on energy partition between carbohydrate (glucose) and lipids, including their regulation systems. Curiously, the study of proteins has been neglected despite being a key nutritional source of energy. Probably, the present situation of limited knowledge is a compounded consequence of the relatively large number of different molecular species, their easy interconversion, the multiple catabolic paths followed by their hydrocarbon skeletons, the methodological difficulties of tracing the fate of N, its close relationship with protein turnover, a multiplicity of functional amino acid pools coupled with an active inter-organ metabolism, and last, but not least, an excessively sketchy knowledge of their catabolic paths and regulation in man (mammals).

Irrespective of the lack of information, the manipulation of protein content of diets has been actively developed for at least half a century, mainly by using hyperproteic very-low-energy diets for the treatment of obesity(Reference Scalfi, Alfieri and Borrelli5, Reference Gougeon, Hoffer and Pencharz6), with serious problems often arising from their application(Reference Doherty, Wadden and Zuk7). There has been a considerable utilisation of low-carbohydrate diets, in which the protein component is conspicuous(Reference Johnstone, Horgan and Murison8, Reference Willi, Oexmann and Wright9), but most of the discussion of their effects has been centred on their ketogenic (i.e. lipid, absence of carbohydrate) nature(Reference Yancy, Olsen and Guyton10), the amino acids essentially being considered potential gluconeogenic substrates(Reference Sankar and Sotero de Menezes11), with little impact on protein synthesis(Reference Masanés, Fernández-López and Alemany12). More recently, the use of hyperproteic diets(Reference Uebanso, Taketani and Fukaya13) is again on the rise, but we still lack the necessary basic knowledge to interpret the results obtained, largely because of few systematic analyses and the continued stress on their ketogenic nature(Reference Johnstone, Horgan and Murison8, Reference Willi, Oexmann and Wright9).

However, under conditions of abundant food supply, the main question is not how amino acids fare under conditions of low energy availability, but the contrary: how the metabolic machinery can override the strong protective mechanisms preventing N wasting under conditions of excess energy (i.e. lipid, carbohydrate and protein) intake. There are few studies on how amino acids are used as substrates, especially on the fate of N under conditions of excess energy intake or obesity. In the present review, the main questions posed by the combination of excess energy and amino-N availability are analysed under the light of the scarce information available.

Amino acids as energy substrates: amino-nitrogen sparing

One of the most significant differences between what our ancestors ate (i.e. the diet for which our digestive system and metabolic energy partitioning are geared and optimised) and the present-day diet is, in addition to the overwhelming abundance of lipid, the constant presence of protein, with a relatively high proportion of high-quality protein. The tandem lipid–animal protein is substituting progressively complex carbohydrate–low-quality plant protein as the main dietary staple. The proportion of protein energy v. total energy intake is not too much different today from the ancestral diet(Reference Frassetto, Schloetter and Mietus-Synder14), but the total amount of energy (after correcting for exercise) is higher, as is the proportion of essential amino acids(Reference Eaton and Eaton15), whilst the relationship between dietary amino acids v. glucose derived from dietary sources tends to change as a direct consequence of the substitution of starches by fats(Reference Brooks and Lampi16).

Our starvation resistance-prone mechanisms of adaptation preserve the use of amino acids as energy substrate when there is sufficient energy in the gut(Reference Oke and Loerch17). In addition, both amino acids and glucose are spared when (if) the availability of lipid is high(Reference Hart, Wolf and Zhang18, Reference Kawaguchi, Osatomi and Yamashita19). In consequence, a diet rich in energy and lipids, with a sizeable proportion of easily digestible protein, rich in essential amino acids, will necessarily result in difficulties to process and oxidise the amino acid surplus, since we are metabolically conditioned to actively preserve them. However, under excess-energy diets (including protein), it is no longer necessary to retain so much amino-N and essential amino acids. Amino acids are used for energy when in relative excess(Reference Stoll, Henry and Reeds20, Reference Wolfram and Scharrer21), but the even higher availability of energy from other sources strongly limits our metabolic machinery to do so(Reference Esteve, Rafecas and Fernández-López22).

Amino acid catabolism tends to retain 2-amino-N, largely because most amino acid hydrocarbon skeletons are oxidised after transamination (typically to 2-oxoglutarate/glutamate). However, a few amino acids yield directly ammonia (Table 1). A quantitative analysis of several common food proteins shows that, as expected, the theoretical direct yield of 2-amino-N is much higher than that of direct ammonium production (Table 2). Thus, the parity needed to synthesise our main N excretion product, urea, requires (in a dietary equilibrium) the additional conversion of a varying proportion of dietary 2-amino-N to ammonium to reach the required (1:1) balance. The ratio amino-N:ammonium-N in most dietary proteins is close to 2 (Table 2), which leaves a wide margin for preservation of N under conditions of starvation, but in the end requires the mineralisation of about half of all amino-N to ammonia under normal feeding conditions.

Table 1 Main amino acid (AA) catabolism pathways in man (adapted from Ferrer-Lorente et al. (Reference Ferrer-Lorente, Fernández-López and Alemany130))*

THF, tetrahydrofolate; [trans to], transamination to; UC, urea cycle; AcCoA, acetyl-coenzyme A; [KC], Krebs or tricarboxylic acid cycle; pyr, pyruvate; [1-C], one-carbon pathways (essentially via THF); succ, succinate; OAA, oxaloacetate; [dehydrogen to], dehydrogenation to; [oxid to], oxidation to; PNC, purine nucleotide cycle; [BO], β-oxidation pathway; AcAc, acetoacetate; AcAcCoA, acetoacetyl-coenzyme A.

* All values are estimations based on the scant data available from human subjects and other mammals; flow of amino acid catabolism via a given path depends largely on the size of amino-N pool, energy availability, metabolic needs and the relative abundance of the amino acid (essential amino acids).

Table 2 Amino acid (AA) content of a number of common food proteins, showing the -NH2:NH3 ratio that would be theoretically generated from the complete oxidation in the body of its constituent amino acids*

* The data have been calculated from standard protein amino acid composition tables(131) and the yield in free ammonium and transaminable 2-amino groups resulting from the complete catabolism of these amino acids (Table 1). Since urea excretion requires equal proportions of amino and ammonium, any -NH2:NH3 ratio above 1·00 represents a relative excess of amino groups, which may be further converted to ammonium via the purine nucleotide cycle or (in certain tissues and physiological conditions) by glutamate dehydrogenase. The ammonium yield of the proteins listed may be underestimated, since most of the data gathered give a combined Glu + Gln (Glx) value in the overall analyses. From the analysis of whole rat protein(Reference Rafecas, Esteve and Fernández-López132) in which amide-N was analysed separately, we assumed, conservatively, and for the sake of these calculations only, that half the Glx values corresponded to Gln and half to Glu; this correction has been included in the calculations and is reflected in the data shown in the Table.

When active (exercise), muscle uses most of the body energy available: its standard feed is glucose, but blood lipids (fatty acids) limit glucose uptake and favour fatty acid oxidation (insulin resistance)(Reference Cahová, Vavrínková and Kazdová23). Some amino acids are oxidised in muscle (especially branched-chain(Reference Shinnick and Harper24)) in the postprandial state to save glucose, but excess energy hampers the process and its timing, since in fact there is no real scarcity of glucose. Amino-N conversion into ammonia is largely done in the liver and muscle through the purine nucleotide cycle(Reference Goodman and Lowenstein25), and its operation is both linked to active glycolysis(Reference Tornheim and Lowenstein26) and increased AMP levels (i.e. low ATP availability, partly compensated by the action of adenylate kinase)(Reference Atkinson and Walton27); thus, under excess energy availability, the cycle is largely idle. Glutamate dehydrogenases play a key role in ammonium metabolism in micro-organisms(Reference Núñez de Castro, Arias-Saavedra and Machado28), and in the muscle of invertebrates(Reference Batrel and Regnault29). However, Their role in ammoniagenesis in mammalian muscle is limited, because of the predominance of the purine nucleotide cycle(Reference Lowenstein30) in this role, and the low presence of the enzyme compared with the liver(Reference Arola, Palou and Remesar31), unaltered under starvation(Reference Remesar, Arola and Palou32). In the liver (and kidney), the activity of glutamate dehydrogenase is considerable(Reference Arola, Palou and Remesar31), but its function is clearly that of resynthesising glutamate from 2-ketoglutaratre and excess ammonia, as determined by direct studies and the analysis of its kinetic constrictions(Reference McGivan and Chappell33Reference Bailey, Bell and Bell35).

Equilibrium between amino-nitrogen and ammonia for urea synthesis

Thus, in muscle there is no other major way to produce ammonia than the purine nucleotide cycle(Reference Lowenstein30). In consequence the muscle cannot use amino acids as an energy source in significant amounts(Reference Flanagan, Holmes and Sabina36) and to use their N to produce and release glutamine. This is an important question, since glutamine is the main form of blood transport of ammonia, towards the splanchnic bed(Reference Marliss, Aoki and Pozefsky37), i.e. intestine and kidney; there, glutaminases free the ammonia again for its ultimate disposal as urea(Reference Wu38), or as urinary ammonium ion(Reference Good and Burg39). Lower muscle synthesis of glutamine results, then, in lower splanchnic synthesis of carbamoyl-P, insufficient to maintain an adequate flow of urea synthesis (Fig. 1). Alternative sources of ammonium, such as the microbiota(Reference Karasawa and Nakata40, Reference Wrong and Vince41), which is in part derived from glutamine(Reference Anderson, Bennett and Alleyne42, Reference Weber, Veach and Friedman43), and the direct ammoniagenic amino acids cited above (serine, threonine, glycine), help maintain a steady albeit diminished rate of urea synthesis in the intestine–liver system, a rate insufficient to cope with the excess 2-amino-N pool generated by the diet and limited amino acid disposal.

Fig. 1 Effect of excess dietary lipid on the main paths of N catabolism, driving to a decrease in the operation of the urea cycle because of lack of conversion of 2-amino-N to ammonium.

High amino acids in conjunction with high energy availability can generate a paradoxical scarcity of ammonia, retaining a large and unshrinkable pool of amino-N because the mechanisms that protect its conversion to ammonia remain unaffected, and are both efficient and effective (and potentially crippling). In the metabolic syndrome (and in general, in energy-rich feeding), urea synthesis is decreased(Reference Barber, Viña and Viña44), but there is not – either – a massive accumulation of body-N(Reference Esteve, Rafecas and Remesar45). Amino acids tend to be preserved in spite of excess energy availability(Reference Serra, Gianotti and Palou46), but in any case, the excess N is eventually lost, albeit not in the canonical way of urea formation(Reference Esteve, Rafecas and Remesar47). A small but significant proportion of N is excreted as N2 gas(Reference Costa, Ullrich and Kantor48, Reference Cissik, Johson and Rokosch49) by means of, so far, unknown pathways. In addition there is an increased (but relatively small) loss of dietary amino-N in the form of urinary nitrate and nitrite(Reference Green, Ruiz de Luzuriaga and Wagner50). Obligatory N losses also include urinary losses of uric acid (from purine catabolism(Reference Sutton, Toews and Ward51)), creatinine and small proportions of peptides and amino acids, as well as the ammonium ion, excreted by the kidney (especially in acidosis)(Reference Desir, Bratusch-Marrain and DeFronzo52). Small amounts of ammonium may be also excreted by the lungs(Reference Robin, Travis and Bromberg53).

Muscle also accumulates fat, near mitochondrial clusters (C Cabot, K Pouillot, S Roy, MM Romero, R Vilà, MM Grasa, M Esteve, JA Fernández-López, M Alemany and X Remesar, unpublished results) and adapts itself to the utilisation of this main substrate (as well as to glucose, but to a lower extent)(Reference Turner, Bruce and Beale54, Reference Lam, Hatznikolas and Weir55). Exercise facilitates the massive utilisation of energy and streamlines the oxidation of fats(Reference Bruce, Thrush and Mertz56), but also restores in part the production of ammonium via the purine nucleotide cycle(Reference Graham, Bangsbo and Saltin57), thus increasing the flow of glutamine to the splanchnic bed. However, a large proportion of glucose, lipids and amino acids can not be taken up by any of the above cited systems, leaving them unused and in high serum concentrations, waiting for their storage as fat in the last-recourse energy pool: white adipose tissue.

The nitric oxide pathway

NO is synthesised from arginine by NO synthases, yielding citrulline(Reference Moncada, Palmer and Higgs58). Excess N availability increases the synthesis of ornithine(Reference Mouillé, Robert and Blachier59), including the intermediate step of acetyl-glutamate synthesis(Reference Tujioka, Lyou and Hirano60), which is also a key regulator of carbamoyl-P synthase 2, and thus also participates in the regulation of ammonium disposal(Reference Saheki, Ohkubo and Katsunuma61). In consequence, higher amino-N levels may increase those of arginine, irrespective of low carbamoyl-P (i.e. low ammonium) availability, shunting the NO cycle from arginine to citrulline and leaving out ornithine (and the synthesis of urea) (Fig. 2 (a) and (b)) (Reference Moncada and Higgs62). In cells that do not have a fully operative urea cycle, the eventual regulation is even easier since it is largely dependent on arginine availability(Reference McCall, Boughton-Smith and Palmer63).

Fig. 2 Possible mechanism of activation of the NO shunt under high energy availability–low ammonium production. (a) Urea cycle function under full operation, i.e. enough ammonium to produce carbamoyl-P and an adequate supply of 2-amino-N through aspartate. (b) Enhancement of the operation of the NO shunt of the urea cycle under limited supply of ammonium (in the form of carbamoyl-P), but maintained supply of 2-amino-N through aspartate. Pi, inorganic phosphate; PPi, inorganic pyrophosphate.

It may be expected, then, that under high energy and amino-N availability, the low ammonia concentrations(Reference Herrero, Angles and Remesar64) can not sustain an effective excretion of N through the urea cycle(Reference Roig, Esteve and Remesar65), indirectly favouring an increased activity of the NO synthesis shunt. The excess NO in blood vessels (derived from the activity of erythrocyte and endothelial NO synthases)(Reference Kleinbongard, Schultz and Rassaf66) may initially raise the blood flow, at least locally, increasing the availability of oxygen and substrates to the surrounding cells(Reference Sureda, Tauler and Aguiló67).

NO is highly reactive and interacts with specific proteins, such as guanylate cyclase(Reference Arnold, Mittal and Katsuki68), increasing the production of cyclic GMP which activates protein kinase G (PKG)(Reference Francis, Busch and Corbin69) which, in turn, relaxes the smooth muscle of small vessels and thus increases blood flow and lowers arterial tension(Reference Lincoln, Komalavilas and Cornwell70). This is the main recognised function of NO(Reference Sessa71), but NO is also able to bind cysteine residues of other proteins, such as protein kinase A (PKA)(Reference Ferro, Coash and Yamamoto72), which may induce a phantom adrenergic stimulation (i.e. without the intervention of catecholamines or cAMP)(Reference Burgoyne and Eaton73).

Cytochrome c also efficiently oxidises NO to nitrite(Reference Torres, Sharpe and Rosquist74). Most of the NO, however, rapidly reacts with oxyhaemoglobin, eventually oxidising NO to nitrate(Reference Gow, Luchsinger and Pawloski75). Other highly reactive NOx compounds, such as peroxynitrite(Reference Huie and Padmaja76), are formed by further oxidation with reactive oxygen species. Part of these nitrogen oxides react with proteins, fatty acids and other compounds yielding nitro-derivatives(Reference Trostchansky and Rubbo77, Reference Rubbo and Radi78), often short-lived, but which can cause permanent structural changes(Reference Jain, Siddam and Marathi79).

Nitrite and other forms of nitrogen excretion

In the obese, the overall production and levels of NO are increased(Reference Asl, Ghasemi and Azizi80), as is its loss in the air breathed(Reference Maniscalco, de Laurentiis and Zedda81), but there is a marked decrease in the excretion of urea(Reference Barber, Viña and Viña44). A significant part of the difference in the N balance is made up of N2 gas(Reference Esteve, Rafecas and Remesar45, Reference Esteve, Rafecas and Remesar47, Reference Cissik, Johnson and Hertig82). A possible source is the reaction of nitrite and free amino acids, which in an acidic medium yield N2 gas and 2-hydroxyacids(Reference Schmidt83); this reaction has been described to occur in the stomach lumen(Reference Yoshida and Kasama84). However, this reaction can hardly explain the large discrepancies found in N balances. There must be another – larger – source of N2 gas integrated in the amino acid metabolism, which so far has not been discovered. We can hypothesise the existence of an ‘emergence’ pathway, shunting the action of NO synthases towards the reaction of arginine with nitrite, yielding citrulline and N2 gas under acidotic conditions. This way, nitrite, the main active product of NO synthesis, would be rapidly removed and, at the same time, the excess 2-amino-N would be decreased at the expense of aspartate-derived arginine guanido-N; unfortunately, no enzyme has been found (so far) able to carry out this reaction, which nevertheless is known to proceed spontaneously under low pH conditions(Reference Schmidt83).

Glucocorticoids may elicit counteractive actions(Reference Worrall, Misko and Sullivan85) to inhibit NO synthesis, but catecholamines increase its production(Reference Lin, Tsai and Huang86). It is unclear whether NO overproduction in the obese can be a consequence of leptin-related catecholamine vasoconstriction(Reference Hall87), a consequence of enhanced NO synthesis through activation of endothelial or inducible NO synthases(Reference Elizalde, Rydén and van Harmelen88), or a lower bioavailability of NO favouring its increased synthesis(Reference Blouet, Mariotti and Mathe89, Reference Williams, Wheatcroft and Shah90).

Nitrite is considered a stabilised form of NO(Reference Tsuchiya, Kanematsu and Yoshizumi91), which can yield NO under hypoxic conditions by reacting with Hb(Reference Piknova, Keszler and Hogg92Reference Lundberg, Weitzberg and Gladwin94), thus helping increase blood flow to hypoxic areas(Reference Ingram, Pinder and Bailey95). Nitrite is also a source of NO in the alimentary canal(Reference Eckmann, Jaurent and Langford96, Reference Lundberg, Weitzberg and Lundberg97); it is largely the product of reduction by the oral biota of nitrate secreted by salivary glands(Reference Chen, Ren and Lu98). Nitrite-derived NO also kills bacteria in the stomach(Reference Iijima, Fyfe and McColl99); in this acidic medium, nitrite reacts with free amino acids yielding N-nitroso-proline from arginine(Reference Ishibashi and Kawabata100), as well as N2 as indicated above(Reference Yoshida and Kasama84).

The ‘obese’ microbiota(Reference Cani, Possemiers and van de Wiele101, Reference Brignardello, Morales and Diaz102) is probably a consequence of this magnified effect of NOx(Reference Dykhuizen, Frazer and Duncan103); changes in the gut microbial ecosystem and composition also influence the relationships with the host through modulation of the immune response(Reference Manco, Putignani and Bottazzo104, Reference Vaarala, Atkinson and Neu105). The relative abundance of protein debris in the intestine, a consequence of diets rich in lipid and protein, together with relatively scarce fibre and polysaccharides, also affects the composition of the microbiota, increasing the share of amino acid-related catabolism in the process of formation of stool(Reference Harmon, Becker and Jensen106, Reference Hughes, Magee and Bingham107). The resulting higher pH, and the production of amines through amino acid decarboxylation(Reference Hughes, Magee and Bingham107), higher proportions of amines, ammonium, as well as amine- and sulfide-related catabolites may also help induce the development of intestinal cancer(Reference Bingham, Pignatelli and Pollock108).

Health consequences of hampered nitrogen excretion in the obese

The main problem posed by this question is the almost absolute lack of information about the human patterns of N excretion in overnutrition, obesity and the metabolic syndrome. It has been found that a relative increase in dietary protein at the expense of carbohydrates facilitates the loss of weight(Reference Lee, Lee and Bae109, Reference Pasiakos, Mettel and West110), but we only know the short-term macroscopic changes; the dynamics of 2-amino-N under these conditions has not been studied.

We have mechanisms to adjust amino acid catabolism to their relative abundance with respect to glucose(Reference Oke and Loerch17), but the large presence of lipids in the diet alters everything. Ketogenic diets favour the excretion of ammonium in the urine to counter the acidosis produced by ketone bodies(Reference Schloeder and Stinebaugh111, Reference Simon, Martin and Buerkert112), and increase liver gluconeogenesis from amino acids(Reference Sherwin, Hendler and Felig113), but the problem of conversion of amino-N to ammonium remains. The possible negative effects of a few truly hyperproteic (i.e. not ketogenic) diets(Reference Metges and Barth114), and their limited effect on body fat point both to a generalised inefficiency of the so-called ‘high-protein’ diets(Reference Johnstone115) and support the relative danger of their uncontrolled application.

One of the most important aspects of amino acid metabolism is the synergistic complementarity of the roles of a number of peripheral organs, the liver and the rest of splanchnic bed organs(Reference Aikawa, Matsutaka and Takezawa116, Reference Felig117). Hyperproteic diets may induce changes in their roles in the absence of energy overload, i.e. under conditions of active amino acid catabolism(Reference Morens, Gaudichon and Fromentin118). However, it is highly improbable that the finely adjusted inter-organ relationships could be maintained under the pressure of high-energy diets, as the low urea output seems to indicate; as a consequence the whole body is affected by an excess of 2-amino-N.

There are few data on human subjects supporting an increase in the synthesis of NO in high-energy availability conditions, except for an increased breath release of NO(Reference Maniscalco, de Laurentiis and Zedda81) and the consequent formation of nitrite and nitrate(Reference Kim-Shapiro, Schechter and Gladwin93, Reference Lundberg, Weitzberg and Gladwin94). Perhaps the high levels of nitrite and the easy interconversion of nitrite and NO(Reference Iijima, Fyfe and McColl99, Reference Gladwin, Crawford and Patel119), a powerful vasodilator(Reference Rees, Palmer and Moncada120), may be related to the ‘obesity paradox’, i.e. a decreased severity of the consequences of heart failure in the obese(Reference Gruberg, Weissman and Waksman121, Reference Badheka, Rathod and Kizilbash122). The large presence of NOx in the alimentary canal and its profound influence on the microbiota has to produce, necessarily, changes in their properties and functions: at least a different way to cope with unused substrates and different relationships with the immune system-controlled intestinal barrier. The latter may be related to the higher levels of circulating lipopolysaccharide observed in the metabolic syndrome(Reference Brun, Castagliuolo and di Leo123), also linked to the maintenance of low-key inflammation(Reference Cancello and Clément124, Reference Matsuo, Hashizume and Shioji125) caused by increased intestinal bacteria activity(Reference Sabate, Jouet and Harnois126). These findings hint to the postulated excess 2-amino-N, in agreement with the higher availability of amino acids and energy to increase protein turnover(Reference Robinson, Jaccard and Persaud127, Reference Yuile, Lucas and Olson128) and to maintain a fully functional immune system(Reference Dunca and Schmidt129) observed in the metabolic syndrome.

Conclusions

Humans are fairly well prepared for amino-N scarcity: dietary protein utilisation is maximised, and amino acid catabolism is restricted in order to preserve body protein, and, with that, to maintain the ability to function and survive. However, the same mechanisms that make possible sparing amino acid catabolism for energy seriously hamper the metabolism of excess dietary amino-N under conditions of overfeeding and excess available energy. Insulin resistance limits the use of glucose when fats are readily available, and ample glucose (energy) availability practically blocks the removal of amino-N to form ammonia, the only, and narrow, canonical way to dispose of excess N. The obese excrete less urea than the lean, high-energy diets inhibit the urea cycle function, but also alter the glucose–alanine cycle and the operation of the purine nucleotide cycle; the path of conversion of amino-N to ammonium is severely restricted. This creates a surplus amino acid availability which enhances growth and protein synthesis, but protein turnover simply stores, and transamination changes, the hydrocarbon skeletons, preserving the amino groups. Consequently, non-conventional mechanisms are necessarily activated (there is no body storage of this surplus N). We do not know how this is accomplished, and only can suggest the possible implication of NO-increased synthesis, followed by higher nitrite (and nitrate) secretion/excretion, and including the production of N2 gas, through a mechanism so far unsolved.

The metabolic consequences of the imbalance between amino- and ammonia-N are far-reaching and should be studied in detail, since probably a number of unexplained phenomena of the metabolic syndrome sink their roots in the profound alteration of N homeostasis. The consequences of excess dietary protein and our inability to dispose of it have not been studied, but the indications obtained from animal studies and the few data available suggest that excess protein is harmful in the long term for humans.

Acknowledgements

The present review was supported by grant no. SAF2009-11739 of the Plan Nacional de Investigación en Biomedicina of the Government of Spain. There are no conflicting interests to disclose.

References

1Felig, P, Owen, OE, Wahren, J, et al. . (1969) Amino acid metabolism during prolonged starvation. J Clin Invest 48, 584594.CrossRefGoogle ScholarPubMed
2Goodman, MN, Belur, E, Lowell, B, et al. . (1984) Sites of protein conservation and loss during starvation. Influence of adiposity. Am J Physiol 246, E383E390.Google ScholarPubMed
3Smith, SR, Pozefsky, T & Chhetri, MK (1974) Nitrogen and amino acid metabolism in adults with protein–calorie malnutrition. Metabolism 23, 603618.CrossRefGoogle ScholarPubMed
4Frenk, S (1986) Metabolic adaptation in protein–energy malnutrition. J Am Coll Nutr 5, 371381.CrossRefGoogle ScholarPubMed
5Scalfi, L, Alfieri, R, Borrelli, R, et al. . (1987) Protein balance during very-low-calorie diets for the treatment of severe obesity. Ann Nutr Metab 31, 154159.CrossRefGoogle ScholarPubMed
6Gougeon, R, Hoffer, LJ, Pencharz, PB, et al. . (1992) Protein metabolism in obese subjects during a very-low-energy diet. Am J Clin Nutr 56, S249S254.CrossRefGoogle ScholarPubMed
7Doherty, JU, Wadden, TA, Zuk, L, et al. . (1991) Long-term evaluation of cardiac function in obese patients treated with a very-low-calorie diet. A controlled clinical study of patients without underlying cardiac disease. Am J Clin Nutr 53, 854858.CrossRefGoogle Scholar
8Johnstone, AM, Horgan, GW, Murison, SD, et al. . (2008) Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr 87, 4455.CrossRefGoogle ScholarPubMed
9Willi, SM, Oexmann, MJ, Wright, NM, et al. . (1998) The effects of a high-protein, low-fat, ketogenic diet on adolescents with morbid obesity: body composition, blood chemistries, and sleep abnormalities. Pediatrics 101, 6167.CrossRefGoogle ScholarPubMed
10Yancy, WS, Olsen, MK, Guyton, JR, et al. . (2004) A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia. A randomized, controlled trial. Ann Intern Med 140, 769777.CrossRefGoogle ScholarPubMed
11Sankar, R & Sotero de Menezes, M (1999) Metabolic and endocrine aspects of the ketogenic diet. Epilepsy Res 37, 191201.CrossRefGoogle ScholarPubMed
12Masanés, RM, Fernández-López, JA, Alemany, M, et al. . (1999) Effect of dietary protein content on tissue protein synthesis rates in Zucker lean rats. Nutr Res 19, 10171026.CrossRefGoogle Scholar
13Uebanso, T, Taketani, Y, Fukaya, M, et al. . (2009) Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am J Physiol 297, E76E84.Google ScholarPubMed
14Frassetto, LA, Schloetter, M, Mietus-Synder, M, et al. . (2009) Metabolic and physiologic improvements from consuming a paleolithic, hunter–gatherer type diet. Eur J Clin Nutr 63, 947955.CrossRefGoogle ScholarPubMed
15Eaton, SB & Eaton, SB III (2000) Paleolithic v. modern diets – selected pathophysiological implications. Eur J Nutr 39, 6770.CrossRefGoogle Scholar
16Brooks, SPJ & Lampi, BJ (1995) The effect of changing dietary fat and carbohydrate on the enzymes of amino acid metabolism. J Nutr Biochem 6, 414421.CrossRefGoogle Scholar
17Oke, BO & Loerch, SC (1992) Effects of energy and amino acid supply to the small intestine on amino acid metabolism. J Nutr Biochem 3, 6266.CrossRefGoogle Scholar
18Hart, DW, Wolf, SE, Zhang, XJ, et al. . (2001) Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med 29, 13181324.CrossRefGoogle ScholarPubMed
19Kawaguchi, T, Osatomi, K, Yamashita, H, et al. . (2002) Mechanism for fatty acid ‘sparing’ effect on glucose-induced transcription. Regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem 277, 38293835.CrossRefGoogle ScholarPubMed
20Stoll, B, Henry, J, Reeds, PJ, et al. . (1998) Catabolism dominates the first-pass intestinal metabolism of dietary essential amino acids in milk protein-fed piglets. J Nutr 128, 606614.CrossRefGoogle ScholarPubMed
21Wolfram, S & Scharrer, E (1984) Effect of feeding a high protein diet on amino acid uptake into rat intestinal brush border membrane vesicles. Pflügers Archiv 400, 3439.CrossRefGoogle Scholar
22Esteve, M, Rafecas, I, Fernández-López, JA, et al. . (1993) Dietary amino acid balances in young Wistar rats fed a cafeteria diet. Biochem Mol Biol Int 29, 10691081.Google ScholarPubMed
23Cahová, M, Vavrínková, H, Kazdová, L, et al. . (2007) Glucose-fatty acid interaction in skeletal muscle and adipose tissue in insulin resistance. Physiol Res 56, 115.CrossRefGoogle ScholarPubMed
24Shinnick, FL & Harper, AE (1976) Branched-chain amino acids oxidation by isolated rat tissue preparations. Biochim Biophys Acta 437, 477486.CrossRefGoogle ScholarPubMed
25Goodman, MN & Lowenstein, JM (1977) The purine nucleotide cycle – studies of ammonia production by skeletal muscle in situ and in perfused preparations. J Biol Chem 252, 50545060.CrossRefGoogle ScholarPubMed
26Tornheim, K & Lowenstein, JM (1975) The purine nucleotide cycle. Control of phosphofructokinase and glycolytic oscillations in muscle extracts. J Biol Chem 250, 63046314.CrossRefGoogle ScholarPubMed
27Atkinson, DE & Walton, GM (1967) Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme. J Biol Chem 242, 32393241.CrossRefGoogle ScholarPubMed
28Núñez de Castro, I, Arias-Saavedra, JM, Machado, A, et al. . (1974) Effect of inhibitors of mitochondrial protein synthesis on the NADH and NADPH glutamate dehydrogenases in yeast. Mol Cell Biochem 3, 109111.CrossRefGoogle ScholarPubMed
29Batrel, Y & Regnault, M (1985) Metabolic pathways of ammoniagenesis in the shrimp Crangon crangon L.: possible role of glutamate dehydrogenase. Comp Biochem Physiol 82B, 217222.Google Scholar
30Lowenstein, JM (1972) Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 52, 382414.CrossRefGoogle ScholarPubMed
31Arola, L, Palou, A, Remesar, X, et al. . (1979) NADH and NADPH dependent glutamate dehydrogenase activities in the organs of the rat. IRCS Med Sci 7, 364.Google Scholar
32Remesar, X, Arola, L, Palou, A, et al. . (1980) Distribution of glutamate dehydrogenase activity in the organs of fed and 24 hour fasted rats. IRCS Med Sci 8, 146.Google Scholar
33McGivan, JD & Chappell, JB (1975) On the metabolic function of glutamate dehydrogenase in rat liver. FEBS Lett 52, 17.CrossRefGoogle ScholarPubMed
34Schoolwerth, AC, Nazar, BL & LaNoue, KF (1978) Glutamate dehydrogenase activation and ammonia formation by rat kidney mitochondria. J Biol Chem 254, 61776183.CrossRefGoogle Scholar
35Bailey, J, Bell, ET & Bell, E (1982) Regulation of bovine glutamate dehydrogenase. The effects of pH and ADP. J Biol Chem 257, 55795583.CrossRefGoogle ScholarPubMed
36Flanagan, WF, Holmes, EW, Sabina, RL, et al. . (1986) Importance of purine nucleotide cycle to energy production in skeletal muscle. Am J Physiol 251, C795C802.CrossRefGoogle ScholarPubMed
37Marliss, EB, Aoki, TT, Pozefsky, T, et al. . (1971) Muscle and splanchnic glutamine and glutamate. Metabolism in postabsorptive and starved man. J Clin Invest 50, 814817.CrossRefGoogle Scholar
38Wu, GY (1998) Intestinal mucosal amino acid catabolism. J Nutr 128, 12491252.CrossRefGoogle ScholarPubMed
39Good, DW & Burg, MB (1984) Ammonia production by individual segments of the rat nephron. J Clin Invest 73, 602610.CrossRefGoogle ScholarPubMed
40Karasawa, Y & Nakata, C (1986) Ammonia absorption from different parts of chicken intestine and its quantitative evaluation in situ. Comp Biochem Physiol 84A, 747750.Google Scholar
41Wrong, OM & Vince, A (1984) Urea and ammonia metabolism in the human large intestine. Proc Nutr Soc 43, 7786.CrossRefGoogle ScholarPubMed
42Anderson, NM, Bennett, FI & Alleyne, GAO (1976) Ammonia production by the small intestine of the rat. Biochim Biophys Acta 437, 238243.Google Scholar
43Weber, FL, Veach, G & Friedman, DW (1982) Stimulation of ammonia production from glutamine by intraluminal glucose in small intestine of dogs. Am J Physiol 242, G552G557.Google ScholarPubMed
44Barber, T, Viña, JR, Viña, J, et al. . (1985) Decreased urea synthesis in cafeteria-diet-induced obesity in the rat. Biochem J 230, 675681.CrossRefGoogle ScholarPubMed
45Esteve, M, Rafecas, I, Remesar, X, et al. . (1991) Nitrogen balances of lean and obese Zucker rats subjected to a cafeteria diet. Int J Obes 16, 237244.Google Scholar
46Serra, F, Gianotti, M, Palou, A, et al. . (1991) Dietary obesity shows adaptations of amino-acid metabolism on enzyme activities to save amino nitrogen. Biochem Int 24, 769776.Google ScholarPubMed
47Esteve, M, Rafecas, I, Remesar, X, et al. . (1992) Nitrogen balance discrepancy in Wistar rats fed a cafeteria diet. Biochem Int 26, 687694.Google ScholarPubMed
48Costa, G, Ullrich, L, Kantor, F, et al. . (1988) Production of elemental nitrogen by certain mammals including man. Nature 218, 546551.CrossRefGoogle Scholar
49Cissik, JH, Johson, RE & Rokosch, DK (1972) Production of gaseous nitrogen in human steady-state conditions. J Appl Physiol 32, 155159.CrossRefGoogle ScholarPubMed
50Green, LC, Ruiz de Luzuriaga, K, Wagner, DA, et al. . (1981) Nitrate biosynthesis in man. Proc Nat Acad Sci U S A 78, 77647768.CrossRefGoogle ScholarPubMed
51Sutton, JR, Toews, CJ, Ward, GR, et al. . (1980) Purine metabolism during strenuous muscular exercise in man. Metabolism 29, 254260.CrossRefGoogle ScholarPubMed
52Desir, G, Bratusch-Marrain, P & DeFronzo, RA (1986) Effect of hyperketonemia on renal ammonia excretion in man. Metabolism 35, 736743.CrossRefGoogle ScholarPubMed
53Robin, ED, Travis, DM, Bromberg, PA, et al. . (1959) Ammonia excretion by mammalian lung. Science 129, 270271.CrossRefGoogle ScholarPubMed
54Turner, N, Bruce, CR, Beale, SM, et al. . (2007) Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle. Evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56, 20852092.CrossRefGoogle ScholarPubMed
55Lam, YY, Hatznikolas, G, Weir, JM, et al. . (2011) Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim Biophys Acta 1811, 468475.CrossRefGoogle ScholarPubMed
56Bruce, CR, Thrush, AB, Mertz, VA, et al. . (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291, E99E107.CrossRefGoogle ScholarPubMed
57Graham, T, Bangsbo, J & Saltin, B (1993) Skeletal muscle ammonia production and repeated, intense exercise in humans. Can J Physiol Pharmacol 71, 484490.CrossRefGoogle ScholarPubMed
58Moncada, S, Palmer, RMJ & Higgs, EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109142.Google ScholarPubMed
59Mouillé, B, Robert, V & Blachier, F (2004) Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion. Am J Physiol Gastrointest Liver Physiol 287, G344G351.CrossRefGoogle ScholarPubMed
60Tujioka, K, Lyou, S, Hirano, E, et al. . (2002) Role of N-acetylglutamate concentration on ornithine transport into mitochondria in urea synthesis of rats given proteins of different quality. J Agric Food Chem 50, 74677471.CrossRefGoogle ScholarPubMed
61Saheki, T, Ohkubo, T & Katsunuma, T (1978) Regulation of urea synthesis in rat liver. Increase in the concenrations of ornithine and acetylglutamate in rat liver in response to urea synthesis stimulated by the injection of an ammonium salt. J Biochem 84, 14231430.CrossRefGoogle Scholar
62Moncada, S & Higgs, A (1993) The l-arginine–nitric oxide pathway. N Engl J Med 329, 20022012.Google ScholarPubMed
63McCall, TB, Boughton-Smith, NK, Palmer, RM, et al. . (1989) Synthesis of nitric oxide from l-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 26, 293296.CrossRefGoogle Scholar
64Herrero, MC, Angles, N, Remesar, X, et al. . (1994) Splanchnic ammonia management in genetic and dietary obesity in the rat. Int J Obes 18, 255261.Google ScholarPubMed
65Roig, R, Esteve, M, Remesar, X, et al. . (1997) Regulation of ammonia-metabolizing enzymes expression in the liver of obese rats: differences between genetic and nutritional obesities. Int J Obes 21, 681685.CrossRefGoogle ScholarPubMed
66Kleinbongard, P, Schultz, R, Rassaf, T, et al. . (2006) Red blood cells express a functional endothelial nitric oxide synthase. Blood 107, 29432951.CrossRefGoogle ScholarPubMed
67Sureda, A, Tauler, P, Aguiló, A, et al. . (2006) Blood cell NO synthesis in response to exercise. Nitric Oxide 15, 512.CrossRefGoogle ScholarPubMed
68Arnold, WP, Mittal, CK, Katsuki, S, et al. . (1977) NO activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Nat Acad Sci U S A 74, 32033207.CrossRefGoogle Scholar
69Francis, SH, Busch, JL & Corbin, JD (2010) cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62, 525563.CrossRefGoogle ScholarPubMed
70Lincoln, TM, Komalavilas, P & Cornwell, TL (1994) Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 23, 11411147.CrossRefGoogle ScholarPubMed
71Sessa, WC (2009) Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Hemost 7, 3537.CrossRefGoogle ScholarPubMed
72Ferro, A, Coash, M, Yamamoto, T, et al. . (2004) Nitric oxide-dependent β2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol 143, 397403.CrossRefGoogle ScholarPubMed
73Burgoyne, JR & Eaton, P (2009) Transnitrosylating NO species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to β-adrenergic-like signaling. J Biol Chem 284, 2926029268.CrossRefGoogle ScholarPubMed
74Torres, J, Sharpe, MA, Rosquist, A, et al. . (2000) Cytochrome c oxidase rapidly metabolises nitric oxide to nitrite. FEBS Lett 475, 263266.CrossRefGoogle ScholarPubMed
75Gow, AJ, Luchsinger, BP, Pawloski, JR, et al. . (1999) The oxyhemoglobin reaction of nitric oxide. Proc Nat Acad Sci U S A 96, 90279032.CrossRefGoogle ScholarPubMed
76Huie, RE & Padmaja, S (1993) The reaction of NO with superoxide. Free Rad Res Commun 18, 195199.CrossRefGoogle ScholarPubMed
77Trostchansky, A & Rubbo, H (2008) Nitrated fatty acids: mechanisms of formation, chemical characterization, and biological properties. Free Radic Biol Med 44, 18871896.CrossRefGoogle ScholarPubMed
78Rubbo, H & Radi, R (2008) Protein and lipid nitration: role in redox signaling and injury. Biochim Biophys Acta 1780, 13181324.CrossRefGoogle ScholarPubMed
79Jain, K, Siddam, A, Marathi, A, et al. . (2008) The mechanism of oleic acid nitration by ∙NO2. Free Radic Biol Med 45, 269283.CrossRefGoogle ScholarPubMed
80Asl, SZ, Ghasemi, A & Azizi, F (2008) Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem 41, 13421347.Google Scholar
81Maniscalco, M, de Laurentiis, G, Zedda, A, et al. . (2007) Exhaled nitric oxide in severe obesity: effect of weight loss. Resp Physiol Neurobiol 156, 370373.CrossRefGoogle ScholarPubMed
82Cissik, JH, Johnson, RE & Hertig, BA (1972) Production of gaseous nitrogen during human steady state exercise. Aerospace Med 43, 12451250.Google ScholarPubMed
83Schmidt, CLA (1929) The reaction between nitrous acid and certain amino acids related compounds at 45°. J Biol Chem 82, 587594.CrossRefGoogle Scholar
84Yoshida, K & Kasama, K (1987) Biotransformation of nitric oxide. Environm Health Perspect 73, 201206.CrossRefGoogle ScholarPubMed
85Worrall, NK, Misko, TP, Sullivan, PM, et al. . (1996) Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation 61, 324328.CrossRefGoogle ScholarPubMed
86Lin, WC, Tsai, PS & Huang, CJ (2005) Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A. Anesth Analg 101, 226232.CrossRefGoogle ScholarPubMed
87Hall, JE (2000) Pathophysiology of obesity hypertension. Curr Hypertens Rep 2, 139147.CrossRefGoogle ScholarPubMed
88Elizalde, M, Rydén, M, van Harmelen, V, et al. . (2000) Expression of nitric oxide synthesis in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 41, 12441251.CrossRefGoogle ScholarPubMed
89Blouet, C, Mariotti, F, Mathe, V, et al. . (2007) Nitric oxide bioavailability and not production is first altered during the onset of insulin resistance in sucrose-fed rats. Exp Biol Med 232, 14581464.CrossRefGoogle Scholar
90Williams, IL, Wheatcroft, SB, Shah, AM, et al. . (2002) Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obesity 26, 754764.CrossRefGoogle ScholarPubMed
91Tsuchiya, K, Kanematsu, Y, Yoshizumi, M, et al. . (2004) Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 288, H2163H2170.CrossRefGoogle ScholarPubMed
92Piknova, B, Keszler, A, Hogg, N, et al. . (2009) The reaction of cell-free oxyhemoglobin with nitrite under physiologically relevant conditions. Implications for nitrite-based therapies. Nitric Oxide 20, 8894.CrossRefGoogle ScholarPubMed
93Kim-Shapiro, DB, Schechter, AN & Gladwin, MT (2006) Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 26, 697705.CrossRefGoogle ScholarPubMed
94Lundberg, JO, Weitzberg, E & Gladwin, MT (2008) The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7, 156167.CrossRefGoogle ScholarPubMed
95Ingram, TE, Pinder, AG, Bailey, DM, et al. . (2010) Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitrite. Am J Physiol Heart Circ Physiol 298, H331H339.CrossRefGoogle Scholar
96Eckmann, L, Jaurent, F, Langford, TD, et al. . (2000) Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 164, 14781487.CrossRefGoogle ScholarPubMed
97Lundberg, JO, Weitzberg, E, Lundberg, JM, et al. . (1994) Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35, 15431546.CrossRefGoogle ScholarPubMed
98Chen, C, Ren, F, Lu, T, et al. . (2010) Involvement of salivary glands in regulating the human nitrate and nitrite levels. Arch Oral Biol 55, 613620.CrossRefGoogle ScholarPubMed
99Iijima, K, Fyfe, V & McColl, KEL (2003) Studies of nitric oxide generation from salivary nitrite in human gastric juice. Scand J Gastroenterol 38, 246252.CrossRefGoogle ScholarPubMed
100Ishibashi, T & Kawabata, T (1981) Formation of N-nitrosoproline by reacting nitrite with l-citrulline and l-arginine. J Agric Food Chem 29, 1099–1089.CrossRefGoogle ScholarPubMed
101Cani, PD, Possemiers, S, van de Wiele, T, et al. . (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 10911103.CrossRefGoogle ScholarPubMed
102Brignardello, J, Morales, P, Diaz, E, et al. . (2010) Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Alim Pharmacol Ther 32, 13071314.CrossRefGoogle ScholarPubMed
103Dykhuizen, RS, Frazer, R, Duncan, C, et al. . (1996) Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense. Antimicrob Agents Chemother 40, 14221425.CrossRefGoogle ScholarPubMed
104Manco, M, Putignani, L & Bottazzo, GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31, 817844.CrossRefGoogle ScholarPubMed
105Vaarala, O, Atkinson, MA & Neu, J (2008) The ‘perfect storm’ for type 1 diabetes. The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57, 25552562.CrossRefGoogle ScholarPubMed
106Harmon, BG, Becker, DE, Jensen, AH, et al. . (1968) Influence of microbiota on metabolic fecal nitrogen in rats. J Nutr 96, 391396.CrossRefGoogle ScholarPubMed
107Hughes, R, Magee, EAM & Bingham, S (2000) Protein degradation in the large intestine: relevance to colorectal cancer. Curr Iss Intest Microbiol 1, 5158.Google ScholarPubMed
108Bingham, SA, Pignatelli, B, Pollock, JRA, et al. . (1996) Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 17, 515523.CrossRefGoogle ScholarPubMed
109Lee, K, Lee, J, Bae, WK, et al. . (2009) Efficacy of low-calorie, partial meal replacement diet plans on weight and abdominal fat in obese subjects with metabolic syndrome: a double-blind, randomised controlled trial of two diet plans – one high in protein and one nutritionally balanced. Int J Clin Pract 63, 195201.CrossRefGoogle ScholarPubMed
110Pasiakos, SM, Mettel, JB, West, K, et al. . (2008) Maintenance of resting energy expenditure after weight loss in premenopausal women: potential benefits of a high-protein, reduced-calorie diet. Metabolism 57, 458464.CrossRefGoogle ScholarPubMed
111Schloeder, FX & Stinebaugh, BJ (1977) Urinary ammonia content as a determinant of urinary pH during chronic metabolic acidosis. Metabolism 26, 13211331.CrossRefGoogle ScholarPubMed
112Simon, E, Martin, D & Buerkert, J (1983) Handling of ammonium by the renal proximal tubule during acute metabolic acidosis. Am J Physiol Renal Physiol 245, F680F686.CrossRefGoogle ScholarPubMed
113Sherwin, RS, Hendler, RG & Felig, P (1975) Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest 55, 13821390.CrossRefGoogle ScholarPubMed
114Metges, CC & Barth, CA (2000) Metabolic consequences of a high dietary-protein intake in adulthood: assessment of the available evidence. J Nutr 130, 886889.CrossRefGoogle ScholarPubMed
115Johnstone, AM (2009) High-protein diets for appetite control and weight loss – the ‘holy grail’ of dieting? Br J Nutr 101, 17291730.CrossRefGoogle ScholarPubMed
116Aikawa, T, Matsutaka, H, Takezawa, K, et al. . (1972) Gluconeogenesis and amino acid metabolism 1. Comparison of various precursors for hepatic gluconeogenesis in vivo. Biochim Biophys Acta 279, 234244.CrossRefGoogle Scholar
117Felig, P (1973) The glucose–alanine cycle. Metabolism 22, 179207.CrossRefGoogle ScholarPubMed
118Morens, C, Gaudichon, C, Fromentin, G, et al. . (2001) Daily delivery of dietary nitrogen to the periphery is stable in rats adapted to increased protein intake. Am J Physiol Endocrinol Metab 281, E826E896.CrossRefGoogle Scholar
119Gladwin, MT, Crawford, JH & Patel, RP (2004) The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 36, 707717.CrossRefGoogle ScholarPubMed
120Rees, DD, Palmer, RM & Moncada, S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Nat Acad Sci USA 86, 33753378.CrossRefGoogle ScholarPubMed
121Gruberg, L, Weissman, NJ, Waksman, R, et al. . (2002) The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39, 578584.CrossRefGoogle ScholarPubMed
122Badheka, AO, Rathod, A, Kizilbash, MA, et al. . (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123, 646651.CrossRefGoogle ScholarPubMed
123Brun, P, Castagliuolo, I, di Leo, V, et al. . (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol 292, G518G525.Google ScholarPubMed
124Cancello, R & Clément, K (2006) Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. Br J Obstet Gynaecol 113, 11411147.CrossRefGoogle ScholarPubMed
125Matsuo, Y, Hashizume, T, Shioji, S, et al. . (2008) Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease. Circ J 72, 20462050.CrossRefGoogle ScholarPubMed
126Sabate, JM, Jouet, P, Harnois, F, et al. . (2008) High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 18, 371377.CrossRefGoogle ScholarPubMed
127Robinson, SM, Jaccard, C, Persaud, C, et al. . (1990) Protein-turnover and thermogenesis in response to high-protein and high-carbohydrate feeding in men. Am J Clin Nutr 52, 7280.CrossRefGoogle ScholarPubMed
128Yuile, CL, Lucas, EV, Olson, JP, et al. . (1959) Plasma protein turnover and tissue exchange. Influence of dietary protein and protein depletion. J Exp Med 109, 173186.CrossRefGoogle ScholarPubMed
129Dunca, BB & Schmidt, MI (2001) Chronic activation of the innate immune system may underlie the metabolic syndrome. S Paulo Med J 119, 122127.CrossRefGoogle Scholar
130Ferrer-Lorente, R, Fernández-López, JA & Alemany, M (2007) Estimation of the metabolizable energy equivalence of dietary proteins. Eur J Nutr 46, 111.CrossRefGoogle ScholarPubMed
131Food Policy and Food Science Service (1981) Amino-Acid Content of Foods and Biological Data on Proteins. Rome: FAO.Google Scholar
132Rafecas, I, Esteve, M, Fernández-López, JA, et al. . (1994) Whole rat protein content estimation. Applicability of the N ×  6·25 factor. Br J Nutr 72, 199209.CrossRefGoogle Scholar
Figure 0

Table 1 Main amino acid (AA) catabolism pathways in man (adapted from Ferrer-Lorente et al.(130))*

Figure 1

Table 2 Amino acid (AA) content of a number of common food proteins, showing the -NH2:NH3 ratio that would be theoretically generated from the complete oxidation in the body of its constituent amino acids*

Figure 2

Fig. 1 Effect of excess dietary lipid on the main paths of N catabolism, driving to a decrease in the operation of the urea cycle because of lack of conversion of 2-amino-N to ammonium.

Figure 3

Fig. 2 Possible mechanism of activation of the NO shunt under high energy availability–low ammonium production. (a) Urea cycle function under full operation, i.e. enough ammonium to produce carbamoyl-P and an adequate supply of 2-amino-N through aspartate. (b) Enhancement of the operation of the NO shunt of the urea cycle under limited supply of ammonium (in the form of carbamoyl-P), but maintained supply of 2-amino-N through aspartate. Pi, inorganic phosphate; PPi, inorganic pyrophosphate.